Charles River Laboratories Fiscal Q3 Non-GAAP Earnings Increase, Revenue Falls; Raises 2026 Guidance

07:25 AM EST, 11/04/2026 (MT Newswires) -- Charles River Laboratories (CRL) reported fiscal Q3 non-GAAP earnings Wednesday of $3.09 per diluted share, compared with $2.43 a year earlier. Analysts surveyed by FactSet expected $2.97. Revenue for the quarter ended Sept. 26 was $982.7 million, compared with $1 billion a year earlier. Analysts expected $960.4 million. The company raised its 2026 non-GAAP EPS guidance to a range of $11.35 to $11.55, compared with the prior outlook of $11.15 to $11.45. Analysts expect $11.38. Full-year revenue is now expected to decline 2% to 1.5%, compared with a decline of 3.5% to 2.5% previously. Shares of the company were up 2.8% in premarket activity Wednesday.